(SBH) Sally Beauty Holdings - Ratings and Ratios
Beauty,Hair,Retail,Products,Stores
SBH EPS (Earnings per Share)
SBH Revenue
Description: SBH Sally Beauty Holdings August 27, 2025
Sally Beauty Holdings Inc (NYSE:SBH) is a US-based company operating in the Other Specialty Retail sub-industry, primarily engaged in the distribution of professional beauty supplies. The companys stock performance is characterized by a relatively high beta of 1.304, indicating a higher volatility compared to the overall market.
Key financial metrics suggest that SBH is undervalued, with a low Price-to-Earnings (P/E) ratio of 7.23 and a Forward P/E of 6.83. This, combined with a Return on Equity (RoE) of 28.24%, indicates that the company is generating significant profits relative to its equity, making it an attractive investment opportunity.
The companys market capitalization stands at $1.323 billion, categorizing it as a mid-cap stock. To further evaluate SBHs performance, key economic drivers such as the overall demand for beauty and cosmetic products, competition in the specialty retail space, and the companys ability to maintain its pricing power and profit margins should be considered.
Important KPIs to monitor for SBH include same-store sales growth, gross margin expansion, and operating expense ratios. Additionally, the companys debt-to-equity ratio and interest coverage ratio would provide insights into its financial health and ability to service its debt. A thorough analysis of these metrics would help investors make informed decisions about the stock.
The stocks technical indicators, such as its position above its 20-day, 50-day, and 200-day Simple Moving Averages (SMA20, SMA50, SMA200), suggest a positive trend. The Average True Range (ATR) indicates a moderate level of price volatility, which, combined with the stocks beta, underscores the need for investors to be prepared for potential price swings.
SBH Stock Overview
| Market Cap in USD | 1,495m |
| Sub-Industry | Other Specialty Retail |
| IPO / Inception | 2006-11-17 |
SBH Stock Ratings
| Growth Rating | 7.60% |
| Fundamental | 60.8% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | -6.01% |
| Analyst Rating | 3.40 of 5 |
SBH Dividends
Currently no dividends paidSBH Growth Ratios
| Growth Correlation 3m | 55.5% |
| Growth Correlation 12m | 30% |
| Growth Correlation 5y | -63.8% |
| CAGR 5y | 5.49% |
| CAGR/Max DD 3y (Calmar Ratio) | 0.09 |
| CAGR/Mean DD 3y (Pain Ratio) | 0.17 |
| Sharpe Ratio 12m | -1.36 |
| Alpha | -15.51 |
| Beta | 1.339 |
| Volatility | 46.33% |
| Current Volume | 2506.1k |
| Average Volume 20d | 1983.3k |
| Stop Loss | 13.8 (-4.4%) |
| Signal | -0.38 |
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income (194.0m TTM) > 0 and > 6% of Revenue (6% = 221.4m TTM) |
| FCFTA 0.07 (>2.0%) and ΔFCFTA 0.87pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 20.00% (prev 18.03%; Δ 1.97pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.10 (>3.0%) and CFO 264.6m > Net Income 194.0m (YES >=105%, WARN >=100%) |
| Net Debt (1.40b) to EBITDA (381.0m) ratio: 3.67 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.41 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (103.2m) change vs 12m ago -2.51% (target <= -2.0% for YES) |
| Gross Margin 51.39% (prev 49.98%; Δ 1.40pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 135.0% (prev 136.1%; Δ -1.08pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 4.91 (EBITDA TTM 381.0m / Interest Expense TTM 67.3m) >= 6 (WARN >= 3) |
Altman Z'' 4.01
| (A) 0.27 = (Total Current Assets 1.26b - Total Current Liabilities 523.8m) / Total Assets 2.74b |
| (B) 0.31 = Retained Earnings (Balance) 863.3m / Total Assets 2.74b |
| (C) 0.12 = EBIT TTM 330.1m / Avg Total Assets 2.73b |
| (D) 0.39 = Book Value of Equity 762.9m / Total Liabilities 1.98b |
| Total Rating: 4.01 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 60.75
| 1. Piotroski 5.0pt = 0.0 |
| 2. FCF Yield 6.46% = 3.23 |
| 3. FCF Margin 5.07% = 1.27 |
| 4. Debt/Equity 1.98 = 0.80 |
| 5. Debt/Ebitda 3.67 = -2.42 |
| 6. ROIC - WACC (= 9.12)% = 11.40 |
| 7. RoE 28.24% = 2.35 |
| 8. Rev. Trend -47.02% = -3.53 |
| 9. EPS Trend -47.14% = -2.36 |
What is the price of SBH shares?
Over the past week, the price has changed by -4.06%, over one month by -12.49%, over three months by +23.76% and over the past year by +11.77%.
Is Sally Beauty Holdings a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SBH is around 14.20 USD . This means that SBH is currently overvalued and has a potential downside of -1.59%.
Is SBH a buy, sell or hold?
- Strong Buy: 2
- Buy: 0
- Hold: 2
- Sell: 0
- Strong Sell: 1
What are the forecasts/targets for the SBH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 15.1 | 4.9% |
| Analysts Target Price | 15.1 | 4.9% |
| ValueRay Target Price | 15.5 | 7.1% |
SBH Fundamental Data Overview November 03, 2025
P/E Trailing = 8.1676
P/E Forward = 7.9872
P/S = 0.4052
P/B = 2.1023
P/EG = 1.037
Beta = 1.339
Revenue TTM = 3.69b USD
EBIT TTM = 330.1m USD
EBITDA TTM = 381.0m USD
Long Term Debt = 882.4m USD (from longTermDebt, last quarter)
Short Term Debt = 315.2m USD (from shortTermDebt, last quarter)
Debt = 1.51b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.40b USD (from netDebt column, last quarter)
Enterprise Value = 2.89b USD (1.50b + Debt 1.51b - CCE 112.8m)
Interest Coverage Ratio = 4.91 (Ebit TTM 330.1m / Interest Expense TTM 67.3m)
FCF Yield = 6.46% (FCF TTM 186.9m / Enterprise Value 2.89b)
FCF Margin = 5.07% (FCF TTM 186.9m / Revenue TTM 3.69b)
Net Margin = 5.26% (Net Income TTM 194.0m / Revenue TTM 3.69b)
Gross Margin = 51.39% ((Revenue TTM 3.69b - Cost of Revenue TTM 1.79b) / Revenue TTM)
Gross Margin QoQ = 51.54% (prev 51.95%)
Tobins Q-Ratio = 1.05 (Enterprise Value 2.89b / Total Assets 2.74b)
Interest Expense / Debt = 1.04% (Interest Expense 15.7m / Debt 1.51b)
Taxrate = 26.80% (16.7m / 62.5m)
NOPAT = 241.7m (EBIT 330.1m * (1 - 26.80%))
Current Ratio = 2.41 (Total Current Assets 1.26b / Total Current Liabilities 523.8m)
Debt / Equity = 1.98 (Debt 1.51b / totalStockholderEquity, last quarter 762.9m)
Debt / EBITDA = 3.67 (Net Debt 1.40b / EBITDA 381.0m)
Debt / FCF = 7.48 (Net Debt 1.40b / FCF TTM 186.9m)
Total Stockholder Equity = 686.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.07% (Net Income 194.0m / Total Assets 2.74b)
RoE = 28.24% (Net Income TTM 194.0m / Total Stockholder Equity 686.9m)
RoCE = 21.04% (EBIT 330.1m / Capital Employed (Equity 686.9m + L.T.Debt 882.4m))
RoIC = 14.95% (NOPAT 241.7m / Invested Capital 1.62b)
WACC = 5.83% (E(1.50b)/V(3.01b) * Re(10.95%) + D(1.51b)/V(3.01b) * Rd(1.04%) * (1-Tc(0.27)))
Discount Rate = 10.95% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.55%
[DCF Debug] Terminal Value 69.49% ; FCFE base≈176.8m ; Y1≈187.5m ; Y5≈223.7m
Fair Price DCF = 25.07 (DCF Value 2.48b / Shares Outstanding 98.9m; 5y FCF grow 6.67% → 3.0% )
EPS Correlation: -47.14 | EPS CAGR: -60.75% | SUE: -4.0 | # QB: 0
Revenue Correlation: -47.02 | Revenue CAGR: -1.11% | SUE: 0.43 | # QB: 0
Additional Sources for SBH Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle